Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gilead Sciences
(NQ:
GILD
)
68.61
-0.22 (-0.32%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
9,590,052
Open
68.83
Bid (Size)
68.15 (20)
Ask (Size)
68.66 (4)
Prev. Close
68.83
Today's Range
68.06 - 69.00
52wk Range
62.07 - 87.86
Shares Outstanding
1,253,809,440
Dividend Yield
4.37%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields
June 28, 2024
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
June 25, 2024
Via
Benzinga
Performance
YTD
-17.58%
-17.58%
1 Month
+7.07%
+7.07%
3 Month
-5.86%
-5.86%
6 Month
-17.58%
-17.58%
1 Year
-10.98%
-10.98%
More News
Read More
Gilead Sciences's Options Frenzy: What You Need to Know
June 24, 2024
Via
Benzinga
7 Dividend Stocks to Buy Now: June 2024
June 23, 2024
Via
InvestorPlace
DraftKings And Dell Were Among The 10 Biggest Large Cap Stock Gainers Last Week (June 16-June 22): Are These In Your Portfolio?
June 23, 2024
Via
Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $800 Today
June 19, 2024
Via
Benzinga
MarketBeat Week in Review – 6/17 - 6/21
June 22, 2024
Via
MarketBeat
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Top Analyst Reports For Abbott, BP & Gilead
June 21, 2024
Via
Talk Markets
Nvidia Snaps 8-Week Winning Run, S&P 500 Marks Longest Streak Without A 2% Drop Since Great Recession, Oil Prices Stage Comeback: This Week In The Market
June 21, 2024
Via
Benzinga
Topics
Economy
Stocks
Exposures
Economy
US Equities
Gilead Sciences Faces Wall Street Speculation About Obesity Drugs Despite Focus On Liver Treatments
June 21, 2024
Via
Benzinga
Why Gilead Sciences Stock Is Trading Higher Friday
June 21, 2024
Via
Benzinga
Pre-Market Movers - June 21, 2024
June 21, 2024
Via
Talk Markets
Gilead Sciences Stock Surges on HIV Treatment Trial Success
June 21, 2024
Via
MarketBeat
Exposures
Product Safety
Defying the Norms: 3 High P/E Stocks With Room to Run
June 21, 2024
Via
InvestorPlace
S&P 500, Nasdaq 100 Dip From Record Highs As Investors Take Chipmaker Profits; Energy Sector Rebounds, Yields Rise: What's Driving Markets Thursday?
June 20, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Gilead Flashes A Bullish Sign After HIV Drug Proves 100% Effective
June 20, 2024
Via
Investor's Business Daily
Why Is Gilead Sciences Stock Trading Higher On Thursday?
June 20, 2024
Via
Benzinga
KB Home Reports Upbeat Earnings, Joins Harrow, Accenture, Gilead Sciences And Other Big Stocks Moving Higher On Thursday
June 20, 2024
Via
Benzinga
Gilead’s Twice-Yearly Lenacapavir Demonstrated 100% Efficacy and Superiority to Daily Truvada® for HIV Prevention
June 20, 2024
From
Gilead Sciences, Inc.
Via
Business Wire
Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7.5 Billion by 2033
June 20, 2024
Via
FinancialNewsMedia
7 Breakthrough Biotech Stocks for a Shot of Portfolio Adrenaline
June 17, 2024
Via
InvestorPlace
Gilead Has A Narrative-Changing Revelation For Its Weight-Loss Contender
June 17, 2024
Via
Investor's Business Daily
Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7.5 Billion by 2033
June 20, 2024
From
FN Media Group LLC
Via
GlobeNewswire
Detailed Data From Gilead Halted Blood Cancer Drug Magrolimab Program Shows Higher Deaths And Side Effects
June 17, 2024
Via
Benzinga
Topics
Death
Exposures
Death
Gilead Sciences Jumps After Its Weight-Loss Drug Emerges From Under The Radar
June 14, 2024
Via
Investor's Business Daily
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.